Carplus expansion plan is double as compare to Comfort , if u believe profit generated in next 2 years , personally I think that glove industry offer the biggest opportunity in this 100 years pandemic crisis...
PETALING JAYA: The global demand for gloves is likely to continue outstripping supply for the next three to four years, even if a vaccine for the Covid-19 becomes available, according to Hartalega Holdings Bhd.
The world’s largest nitrile glove maker says the consumption of gloves worldwide will continue to increase because of changes in user behaviour.
Speaking at a press conference after the group’s AGM yesterday, Hartalega CEO Kuan Mun Leong said the Covid-19 pandemic has changed user behaviour, and that was driving up demand for gloves.
“Demand in developed countries has increased 30%, while in developing countries, demand has more than doubled, ” Mun Leong said.
Due to heightened hygiene and safety awareness, there is now a structural step-up in the use of gloves, he said, adding that this was why the medium-term outlook for glove demand would remain strong.
The industry, he said, was currently facing a huge shortage, with about 120 billion pieces of gloves as additional demand.
“This demand can only be fulfilled in three years, ” Mun Leong said, adding that the industry would not see an oversupply in the next three to four years despite players actively ramping up their production capacities.
Mun Leong pointed out that without the pandemic, global demand for gloves typically expanded at an average of 8%-10% per year.
Meanwhile, Hartalega executive chairman Kuan Kam Hon said the company was constantly expanding at an average rate of about 20% per annum, which was slightly more than the organic growth in the industry.
“For us, the situation for the next three years is that of supply not meeting demand, ” Kam Hon said.
“Even if we have extra gloves by the fourth year, it goes into inventory building. When you have a supply shortage, you are not able to build inventory, ” he added.
On capacity expansion, Mun Leong said Hartalega was currently accelerating growth through its next generation glove manufacturing complex (NGC) to to meet the demand.
“To date, we have commissioned 10 out of 12 production lines for plant six, while for plant seven, the first production line is on-track for completion by October 2020, ” Mun Leong said.
The group recently acquired a 24.23ha land in Sepang, Selangor, adjacent to its NGC plant seven, for RM158mil.
The group plans to build four new plants on that piece of land with an investment of RM1.5bil.
“The first line will start production in October 2021, ” Mun Leong said.
Upon completion, the four new plants would add 19 billion pieces per annum in installed capacity.
In addition, Hartalega is expected to invest RM3bil for its next expansion phase, code-named NGC 2.0 to build seven factories on a 38ha in Banting, Selangor. The first production line is expected to be commissioned in the first half of 2022.
Mun Leong said once fully completed by 2027, Hartalega’s expansion plans would see the group’s total annual installed capacity increase to 95 billion pieces per annum.
Hartalega’s net profit more than doubled to a record RM219.7mil for the first quarter ended June 30,2020, while revenue jumped 44% year-on-year to RM920.1mil.
Mun Leong said Hartalega is expected to continue posting better results in the quarters ahead, supported by rising average selling prices due to strong global demand for gloves.
Glove prices, he said, are now three times as high as they were in pre-Covid-19 days.
This quarter alone, spot prices for gloves jumped 30%, and he expected them to increase 40%-50% in next quarter.
In terms of an increase in global production, CGSCIMB in a recent report noted that China glove makers had announced aggressive expansion plans. “Recent media reports indicate that two China glove makers, Blue Sail Medical and Intco Medical, have ambitious plans to ramp up their nitrile glove production capacity. We gather that Blue Sail aims to raise its nitrile glove production capacity to 36.1 billion by end-2023 from 4.3 billion at end-2019.
“Intco plans to expand its nitrile glove capacity to 59.2 billion per annum by end-2023 from five billion at end-2019.”
Yes, it has built a higher low & has made a strong base, now ready to fly up to a higher high. The last high was at rm5. 83. Wish all loyal careplus investors good luck.
Pfizer just announced its vaccine also got problem...last week was astra zeneca...well glove will continue to reign till next year...as for Russian vaccine, it was a publicity stunt, it's a total scam
plus, WHO and main vaccine world producer, already report, vaccine wont be available soon, better be careful, covid19 mutated, now more contagious than before.
Hehehe tomorrow careplus will limit up again. I think if TG’s results around rm1.2-1.4B, they will go up to rm9.6 and supermax, careplus will gain at least 20pct tomorrow
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
CUTLOST
5,178 posts
Posted by CUTLOST > 2020-09-16 09:11 | Report Abuse
Big Boys always Win.. Just like Mickecyc